Attana AB-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Attana AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011788
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Attana AB (Attana) develops, manufactures and markets reagent kits and chip surfaces. The company offers products such as instruments, chip surfaces, reagents, kits and consumables; softwares, and accessories and spare parts. Its services comprise contract research, instrument training, attana demo, proof of principle studies, assay development services, service and support agreements; application support, attana in-house visits and technical support services. Its products are used in cell-based assay, biochemical assay, accessibility, off-target interaction, avidity, kinetics and affinity; crude sample analysis, serum sample analysis, sandwich pair selection, hybridoma screening and other applications. Attana is headquartered in Stockholm, Sweden.

Attana AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Attana AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Attana AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Attana AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Attana AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Attana AB, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Tecan Extends Distribution Agreement With Attana 9
Attana Enters Into Distribution Agreement With Layerlab For memLayer 10
Tecan Enters Into Distribution Agreement With Attana 11
Attana AB – Key Competitors 12
Attana AB – Key Employees 13
Attana AB – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Government and Public Interest 15
Nov 16, 2017: Attana, Karoliniska Universitetssjukhuset and KTH receives project grant of 4.8 MSEK 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Attana AB, Pharmaceuticals & Healthcare, Key Facts 2
Attana AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Attana AB, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Attana AB, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Attana AB, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Attana AB, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 8
Tecan Extends Distribution Agreement With Attana 9
Attana Enters Into Distribution Agreement With Layerlab For memLayer 10
Tecan Enters Into Distribution Agreement With Attana 11
Attana AB, Key Competitors 12
Attana AB, Key Employees 13

★海外企業調査レポート[Attana AB-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DBV Technologies S.A. (DBV)(製薬・医療分野):企業M&A動向
    Summary DBV Technologies S.A. (DBV) is a biopharmaceutical and healthcare company. It carries out the development of products for the diagnosis and treatment of food and pediatric allergies. The company develops and markets non-invasive epicutaneous delivery technology and products for healthcare ma …
  • UBI Soft Entertainment SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' UBI Soft Entertainment SA Merge …
  • The Hong Kong and China Gas Company Limited:企業の戦略・SWOT・財務分析
    SummaryThe Hong Kong and China Gas Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view …
  • Carrabba’s Italian Grill, Inc.:企業の戦略・SWOT・財務分析
    Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nafais Holding Company KSCC (NAFAIS):企業の財務及び戦略的SWOT分析
    Summary Nafais Holding Company KSCC (Nafais) is an educational service provider that provides services in promoting education in Kuwait by investing and operating educational institutions. The company’s business segments include Education, Health Care and Financing and Investment. Nafais’s Education …
  • Mitchells & Butlers plc:企業のM&A・提携・投資分析
    Mitchells & Butlers plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitchells & Butlers plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • Astute Medical Inc:企業のM&A・提携動向(医療機器分野)
    Summary Astute Medical Inc (Astute Medical) is a medical device company that provides diagnostic products. The company offers biomarker products such as nephro check test and astute meter. Its products are used in identifying and validating biomarkers of acute kidney injury through clinically useful …
  • Hong Kong Jewellery Holding Ltd (8048):企業財務及び戦略的SWOT分析
    Summary Hong Kong Jewellery Holding Ltd (H.K. Jewellery), formerly Excel Technology International Holdings Limited is a technology company that develops software. The company’s activities include research and development, application of software and technology solutions, and operations of chain reta …
  • KPI Therapeutics Inc:企業のM&A・提携動向(医療分野)
    Summary KPI Therapeutics Inc (KPI), formerly Kineta Prime Inc. is a biotechnology company that develops therapies for autoimmunity and chronic pain. The company’s pipeline products comprise Dalazatide, a synthetic peptide for the treatment of autoimmune disorders; KPI-190, an eye drop developed for …
  • Essel Propack Limited:戦略・SWOT・企業財務分析
    Essel Propack Limited - Strategy, SWOT and Corporate Finance Report Summary Essel Propack Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Bass Metals, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bass Metals, Ltd. Mergers and A …
  • Innergex Renewable Energy, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Innergex Renewable Energy, Inc. …
  • Bravura Solutions Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bravura Solutions Limited Merge …
  • ORBIT Communication Systems Ltd.:企業の戦略・SWOT・財務分析
    SummaryORBIT Communication Systems Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the com …
  • Canadian Royalties, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Canadian Royalties, Inc. Merger …
  • Cohera Medical, Inc.:企業のM&A・提携動向(医療機器分野)
    Summary Cohera Medical, Inc. (Cohera) is a medical device company that designs and develops surgical adhesives and sealants for improving patient care. The company offers products such as TissuGlu surgical adhesive, and Sylys surgical sealant. Its TissuGlu surgical adhesive is biocompatible for inte …
  • BellBrook Labs LLC-医療機器分野:企業M&A・提携分析
    Summary BellBrook Labs LLC (BellBrook) is a medical device company that develops detection reagents and screening tools. The company’s biochemical assay technology offers UVO microconduit array platform, chemotaxis assay plate, transcreener HTS assays, ADP² assays, AMP² and GMP² assays, GDP assays, …
  • Chariot Oil & Gas Limited (CHAR):企業の財務及び戦略的SWOT分析
    Summary Chariot Oil & Gas Limited (CHAR) is an oil and gas company that provides oil and gas exploring services. The company offers drilling and extracting services for oil and gas resources. It offers exploration of oil and gas in the areas of Namibia, Mauritania and Morocco. CHAR creates transform …
  • Novavax, Inc.:企業のM&A・提携・投資分析
    Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novavax, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Retail Food Group Limited (Foodservice):企業の戦略・SWOT・財務分析
    SummaryRetail Food Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆